System Transmission

Top Signal

100#1 JOB

Activity

2179Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

INKT

$9.74-5.25%

MiNK Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

5Overripe

Live Analysis Active

Company Mission

MiNK Therapeutics develops cell-based therapies that use natural killer cells, which are part of the immune system, to target and destroy cancer cells. The company works with hospitals and research institutions to test these therapies in clinical trials. It makes money through research grants, partnerships with pharmaceutical companies, and potentially future drug sales if treatments get approved.

INK

Industry Context

The biotechnology industry focuses on developing medical treatments using living cells and biological processes. Companies in this sector often have no products for sale yet and rely on research funding and partnerships. Their stock prices can swing dramatically based on news about clinical trials and scientific discoveries.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

41Matrix

Market Momentum

40.6— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.1x— Normal Volume

Today's Change

-5.25%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing INKT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:23 AM UTC

As-of 03-15-2026 08:08 UTC

Develops immune cell therapies to fight cancer and makes money by partnering with drug companies to advance these treatments.

Price below key moving averages for several weeks, suggesting a downtrend as sellers maintain control over the stock showing consolidation pattern.

Biotech sector faces volatility as investors await clinical trial results, creating uncertainty for companies like Mink Therapeutics, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...